Effectiveness of High-Voltage PRF for Chronic Lumbosacral Radicular Pain
Effectiveness of High-Voltage Pulsed Radiofrequency for Chronic Lumbosacral Radicular Pain: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Central Java
-
Semarang, Central Java, Indonesia, 50112
- RSI Sultan Agung Islamic Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged ≥ 18 years old
- Numeric Rating Scale (NRS-11) ≥ 4 at screening
- Clinical diagnosis of lumbosacral radicular pain with symptom duration ≥ 12 weeks
- Insufficient response to conservative therapy, including but not limited to pharmacotherapy and/or physiotherapy
Exclusion Criteria:
- Known hypersensitivity or allergy to medication required during the study (e.g., steroid, contrast media)
- Coagulopathy, systemic infection, localized infection at needle-entry site, lumbar fracture, myelopathy, or severe organ dysfunction (e.g., renal failure, heart failure, severe respiratory diseases)
- Comorbidities that compromise valid pain assessment (e.g., post-stroke, central neuropathy, malignancy)
- Previous neurological deficits
- Pregnancy
- Refusal of participation in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Standard/Low-Voltage PRF at 45 V
Pulsed Radiofrequency set the voltage at 45 V.
|
A specialist performed fluoroscopy-guided monopolar Pulsed Radiofrequency (PRF) on a prone patient using a 22-gauge cannula (Cosman CC, CR type, 10 cm with a 10 mm active tip).
Sensory stimulation prior to the procedure was applied at 200 Ohm, 50 Hz (threshold: 0.3 - 0.5 V), and motor stimulation at 2 Hz (threshold: 0.9 - 1.5 V).
PRF was applied at a maximum temperature of 42 centigrade, with a frequency of 2 Hz, pulse width of 20 milliseconds, and a duration of 120 seconds per cycle for three cycles.
An operating room nurse set the voltage at 45 V or 60 V.
Other Names:
Post-procedure analgesia in both groups was provided via IV fentanyl 0.5-1 µg/kg, administered as needed for patients reporting an NRS score greater than 4.
This intervention was not a primary focus of the study.
Other Names:
|
|
Experimental: High-Voltage PRF at 60 V
Pulsed Radiofrequency set the voltage at 60 V.
|
A specialist performed fluoroscopy-guided monopolar Pulsed Radiofrequency (PRF) on a prone patient using a 22-gauge cannula (Cosman CC, CR type, 10 cm with a 10 mm active tip).
Sensory stimulation prior to the procedure was applied at 200 Ohm, 50 Hz (threshold: 0.3 - 0.5 V), and motor stimulation at 2 Hz (threshold: 0.9 - 1.5 V).
PRF was applied at a maximum temperature of 42 centigrade, with a frequency of 2 Hz, pulse width of 20 milliseconds, and a duration of 120 seconds per cycle for three cycles.
An operating room nurse set the voltage at 45 V or 60 V.
Other Names:
Post-procedure analgesia in both groups was provided via IV fentanyl 0.5-1 µg/kg, administered as needed for patients reporting an NRS score greater than 4.
This intervention was not a primary focus of the study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in the Numeric rating scale (NRS-11) at Follow Up
Time Frame: Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
Zero is equivalent to no pain and 10 indicates the worst possible pain.
|
Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
|
Change from Baseline in the Visual Analog Scale (VAS) at Follow Up
Time Frame: Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
The Visual Analogue Scale (VAS) is determined by measuring the distance (in millimeters) from the patient's mark on a 100mm line to the left end of the line.
The left endpoint is equivalent to "no pain" and right endpoint represents the "worst imaginable pain."
|
Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Oswestry's Disability Index Score at Follow Up
Time Frame: Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
The Oswestry Disability Index (ODI) was developed to evaluate the degree of disability associated with low back pain (LBP).
An increase of 10% or more from the baseline ODI score is generally considered to indicate a clinically and statistically significant change in the patient's condition.
|
Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
|
Change from Baseline in Serum Interleukin-6 at Follow Up
Time Frame: Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
A reduction or maintenance of serum interleukin-6 levels from baseline at follow-up.
|
Baseline (pre-intervention) through study completion, an average of 6 weeks.
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication and Adverse Event
Time Frame: From enrollment through study completion, an average of 6 weeks.
|
Any complications or adverse events that occurred during the procedure or afterward up to the follow-up period.
|
From enrollment through study completion, an average of 6 weeks.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Farhan A Rahman, MD, RSUP Dr. Sardjito/Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada
- Study Director: Nur S Wirawan, MD, Department of Anesthesiology, Intensive Care, and Pain Management Hasanuddin University
- Study Director: Muhammad R Ahmad, MD, Department of Anesthesiology, Intensive Care, and Pain Management Hasanuddin University
Publications and helpful links
General Publications
- Deyo RA, Mirza SK. CLINICAL PRACTICE. Herniated Lumbar Intervertebral Disk. N Engl J Med. 2016 May 5;374(18):1763-72. doi: 10.1056/NEJMcp1512658. No abstract available.
- Jang JN, Park S, Park JH, Song Y, Kim YU, Kim DS, Sohn JE, Park S. Output Current and Efficacy of Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion in Patients With Lumbar Radiculopathy: A Prospective, Double-blind, Randomized Pilot Study. Pain Physician. 2023 Nov;26(7):E797-E804.
- Erken B, Edipoglu IS. Efficacy of High-Voltage Pulsed Radiofrequency of the Dorsal Root Ganglion for Treatment of Chronic Lumbosacral Radicular Pain: A Randomized Clinical Trial. Neuromodulation. 2024 Jan;27(1):135-140. doi: 10.1016/j.neurom.2022.10.056. Epub 2022 Dec 1.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 28/KEPK-RSISA/I/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.